Baxter International | BAX - Przychody Ze Sprzedaży





Obroty Zmiana Data
Abbott USD 11.16B 300M 2026-03
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 141.2M 700K 2026-03
Avanos Medical USD 182.2M 1.3M 2026-03
Baxter International USD 2.7B 270M 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
Cooper Companies USD 1.08B 57.4M 2026-03
Dexcom USD 1.19B 70M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Fresenius EUR 5.74B 140M 2026-03
Globus Medical USD 759.85M 66.55M 2026-03
Halozyme Therapeutics USD 377M 74.76M 2026-03
ICU Medical USD 525.77M 14.93M 2026-03
Inogen USD 74.93M 504K 2024-09
Insulet USD 761.7M 22.1M 2026-03
Integra LifeSciences USD 391.9M 43M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Laboratory Of America USD 3.54B 20M 2026-03
Masimo USD 403.6M 8.9M 2026-03
Medtronic USD 9.8B 800M 2026-03
Merit Medical Systems USD 381.9M 12M 2026-03
Quest Diagnostics USD 2.9B 90M 2026-03
Smith & Nephew USD 3.18B 353M 2025-12
Stryker USD 6B 1.2B 2026-03
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
Terumo JPY 300.32B 3.69B 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03